Cargando…

Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease

BACKGROUND & AIMS: The value of liver stiffness measurement (LSM) by transient elastography (TE) for non‐invasive fibrosis staging and disease monitoring has not been established in patients with Wilson disease (WD). METHODS: Liver stiffness measurement by TE and non‐invasive fibrosis scores (AP...

Descripción completa

Detalles Bibliográficos
Autores principales: Paternostro, Rafael, Pfeiffenberger, Jan, Ferenci, Peter, Stättermayer, Albert F., Stauber, Rudolf E., Wrba, Fritz, Longerich, Thomas, Lackner, Karoline, Trauner, Michael, Ferlitsch, Arnulf, Reiberger, Thomas, Weiss, Karl Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187206/
https://www.ncbi.nlm.nih.gov/pubmed/31898387
http://dx.doi.org/10.1111/liv.14368
_version_ 1783527125092925440
author Paternostro, Rafael
Pfeiffenberger, Jan
Ferenci, Peter
Stättermayer, Albert F.
Stauber, Rudolf E.
Wrba, Fritz
Longerich, Thomas
Lackner, Karoline
Trauner, Michael
Ferlitsch, Arnulf
Reiberger, Thomas
Weiss, Karl Heinz
author_facet Paternostro, Rafael
Pfeiffenberger, Jan
Ferenci, Peter
Stättermayer, Albert F.
Stauber, Rudolf E.
Wrba, Fritz
Longerich, Thomas
Lackner, Karoline
Trauner, Michael
Ferlitsch, Arnulf
Reiberger, Thomas
Weiss, Karl Heinz
author_sort Paternostro, Rafael
collection PubMed
description BACKGROUND & AIMS: The value of liver stiffness measurement (LSM) by transient elastography (TE) for non‐invasive fibrosis staging and disease monitoring has not been established in patients with Wilson disease (WD). METHODS: Liver stiffness measurement by TE and non‐invasive fibrosis scores (APRI, FIB‐4) were analysed from 188 WD patients with liver biopsy (LBX). Longitudinal LSM was performed in 128 (68.1%) patients. RESULTS: One hundred and eighty‐eight patients (mean age: 35 ± 14 years, 54.8% women; 27.1% with histological cirrhosis) were studied. Forty‐four[23.4%] patients were recently diagnosed with WD, while 144[76.6%] were previously diagnosed (>1 year between LBX and LSM). Overall, LSM (11.3 vs 6.1 kPa, P < .001), APRI (0.72 vs 0.38, P < .001) and FIB‐4 (1.54 vs 0.89, P < .001) were higher in cirrhotic than in non‐cirrhotic patients. This was even more pronounced in recently diagnosed patients (35.2 kPa vs 6.4 kPa, P < .001). Accuracy for diagnosing cirrhosis at an LSM cut‐off ≥9.9 kPa was better in recently diagnosed (PPV: 74%, NPV: 100%) vs previously diagnosed (PPV: 53%, NPV: 82%) patients. Recently diagnosed patients had higher Area Under the Curve (AUC) for APRI (0.79 vs 0.61) and FIB‐4 (0.84 vs 0.65) than previously diagnosed patients. At APRI <1.5 and FIB‐4 <3.25 cirrhosis was ruled out with a specificity of 93% and 95% respectively. During a median follow‐up of 46 (24‐66) months, only 5.9% (5/85) of non‐cirrhotic WD patients showed progression to cirrhotic LSM values, while 30.8% (4/13) of cirrhotic WD patients showed LSM suggestive of cirrhosis regression. CONCLUSION: TE‐based LSM ≥9.9 kPa accurately identifies cirrhosis in WD patients. Next to TE‐LSM <9.9 kPa, APRI <1.5 and FIB‐4 <3.25 values assist to non‐invasively rule out cirrhosis. LSM remains stable in most non‐cirrhotic patients on WD therapy, while one‐third of cirrhotic patients present clinically relevant decreases in LSM.
format Online
Article
Text
id pubmed-7187206
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-71872062020-04-28 Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease Paternostro, Rafael Pfeiffenberger, Jan Ferenci, Peter Stättermayer, Albert F. Stauber, Rudolf E. Wrba, Fritz Longerich, Thomas Lackner, Karoline Trauner, Michael Ferlitsch, Arnulf Reiberger, Thomas Weiss, Karl Heinz Liver Int Genetics and Rare Liver Diseases BACKGROUND & AIMS: The value of liver stiffness measurement (LSM) by transient elastography (TE) for non‐invasive fibrosis staging and disease monitoring has not been established in patients with Wilson disease (WD). METHODS: Liver stiffness measurement by TE and non‐invasive fibrosis scores (APRI, FIB‐4) were analysed from 188 WD patients with liver biopsy (LBX). Longitudinal LSM was performed in 128 (68.1%) patients. RESULTS: One hundred and eighty‐eight patients (mean age: 35 ± 14 years, 54.8% women; 27.1% with histological cirrhosis) were studied. Forty‐four[23.4%] patients were recently diagnosed with WD, while 144[76.6%] were previously diagnosed (>1 year between LBX and LSM). Overall, LSM (11.3 vs 6.1 kPa, P < .001), APRI (0.72 vs 0.38, P < .001) and FIB‐4 (1.54 vs 0.89, P < .001) were higher in cirrhotic than in non‐cirrhotic patients. This was even more pronounced in recently diagnosed patients (35.2 kPa vs 6.4 kPa, P < .001). Accuracy for diagnosing cirrhosis at an LSM cut‐off ≥9.9 kPa was better in recently diagnosed (PPV: 74%, NPV: 100%) vs previously diagnosed (PPV: 53%, NPV: 82%) patients. Recently diagnosed patients had higher Area Under the Curve (AUC) for APRI (0.79 vs 0.61) and FIB‐4 (0.84 vs 0.65) than previously diagnosed patients. At APRI <1.5 and FIB‐4 <3.25 cirrhosis was ruled out with a specificity of 93% and 95% respectively. During a median follow‐up of 46 (24‐66) months, only 5.9% (5/85) of non‐cirrhotic WD patients showed progression to cirrhotic LSM values, while 30.8% (4/13) of cirrhotic WD patients showed LSM suggestive of cirrhosis regression. CONCLUSION: TE‐based LSM ≥9.9 kPa accurately identifies cirrhosis in WD patients. Next to TE‐LSM <9.9 kPa, APRI <1.5 and FIB‐4 <3.25 values assist to non‐invasively rule out cirrhosis. LSM remains stable in most non‐cirrhotic patients on WD therapy, while one‐third of cirrhotic patients present clinically relevant decreases in LSM. John Wiley and Sons Inc. 2020-01-22 2020-04 /pmc/articles/PMC7187206/ /pubmed/31898387 http://dx.doi.org/10.1111/liv.14368 Text en © 2020 The Authors. Liver International published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Genetics and Rare Liver Diseases
Paternostro, Rafael
Pfeiffenberger, Jan
Ferenci, Peter
Stättermayer, Albert F.
Stauber, Rudolf E.
Wrba, Fritz
Longerich, Thomas
Lackner, Karoline
Trauner, Michael
Ferlitsch, Arnulf
Reiberger, Thomas
Weiss, Karl Heinz
Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease
title Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease
title_full Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease
title_fullStr Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease
title_full_unstemmed Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease
title_short Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease
title_sort non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with wilson disease
topic Genetics and Rare Liver Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187206/
https://www.ncbi.nlm.nih.gov/pubmed/31898387
http://dx.doi.org/10.1111/liv.14368
work_keys_str_mv AT paternostrorafael noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease
AT pfeiffenbergerjan noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease
AT ferencipeter noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease
AT stattermayeralbertf noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease
AT stauberrudolfe noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease
AT wrbafritz noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease
AT longerichthomas noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease
AT lacknerkaroline noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease
AT traunermichael noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease
AT ferlitscharnulf noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease
AT reibergerthomas noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease
AT weisskarlheinz noninvasivediagnosisofcirrhosisandlongtermdiseasemonitoringbytransientelastographyinpatientswithwilsondisease